News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,650 Results
Type
Article (47766)
Company Profile (330)
Press Release (694538)
Multimedia
Podcasts (117)
Webinars (18)
Section
Business (209640)
Career Advice (2248)
Deals (36445)
Drug Delivery (124)
Drug Development (82994)
Employer Resources (178)
FDA (16591)
Job Trends (15340)
News (354320)
Policy (33426)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2603)
Accelerated approval (32)
Adcomms (29)
Allergies (139)
Alliances (51122)
ALS (178)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (324)
Approvals (16823)
Artificial intelligence (533)
Autoimmune disease (153)
Automation (37)
Bankruptcy (372)
Best Places to Work (11733)
BIOSECURE Act (21)
Biosimilars (190)
Biotechnology (225)
Bladder cancer (159)
Brain cancer (58)
Breast cancer (640)
Cancer (4874)
Cardiovascular disease (416)
Career advice (1887)
Career pathing (37)
CAR-T (294)
CDC (46)
Celiac Disease (2)
Cell therapy (780)
Cervical cancer (36)
Clinical research (70734)
Collaboration (1772)
Company closure (4)
Compensation (1159)
Complete response letters (62)
COVID-19 (2762)
CRISPR (96)
C-suite (851)
Cystic fibrosis (147)
Data (6241)
Decentralized trials (2)
Denatured (35)
Depression (140)
Diabetes (500)
Diagnostics (6745)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (253)
Drug pricing (195)
Drug shortages (28)
Duchenne muscular dystrophy (235)
Earnings (90983)
Editorial (58)
Employer branding (21)
Employer resources (158)
Events (121209)
Executive appointments (989)
FDA (19715)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1504)
Gene editing (209)
Generative AI (46)
Gene therapy (640)
GLP-1 (1004)
Government (4722)
Grass and pollen (6)
Guidances (384)
Healthcare (19010)
HIV (56)
Huntington's disease (49)
IgA nephropathy (83)
Immunology and inflammation (271)
Immuno-oncology (61)
Indications (105)
Infectious disease (3031)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (247)
Interviews (360)
IPO (16960)
IRA (51)
Job creations (3942)
Job search strategy (1595)
JPM (65)
Kidney cancer (16)
Labor market (84)
Layoffs (580)
Leadership (36)
Legal (8161)
Liver cancer (91)
Longevity (15)
Lung cancer (647)
Lymphoma (379)
Machine learning (44)
Management (62)
Manufacturing (810)
MASH (165)
Medical device (13802)
Medtech (13854)
Mergers & acquisitions (20547)
Metabolic disorders (1299)
Multiple sclerosis (162)
NASH (18)
Neurodegenerative disease (331)
Neuropsychiatric disorders (92)
Neuroscience (2962)
Neurotech (1)
NextGen: Class of 2026 (6687)
Non-profit (4556)
Now hiring (66)
Obesity (618)
Opinion (304)
Ovarian cancer (165)
Pain (206)
Pancreatic cancer (229)
Parkinson's disease (286)
Partnered (34)
Patents (494)
Patient recruitment (480)
Peanut (56)
People (60574)
Pharmaceutical (68)
Pharmacy benefit managers (29)
Phase 1 (22165)
Phase 2 (31177)
Phase 3 (23093)
Pipeline (5173)
Policy (296)
Postmarket research (2588)
Preclinical (9397)
Press Release (72)
Prostate cancer (236)
Psychedelics (53)
Radiopharmaceuticals (282)
Rare diseases (875)
Real estate (6312)
Recruiting (72)
Regulatory (24970)
Reports (51)
Research institute (2441)
Resumes & cover letters (378)
Rett syndrome (28)
RNA editing (18)
RSV (78)
Schizophrenia (150)
Series A (255)
Series B (197)
Service/supplier (13)
Sickle cell disease (102)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3874)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (89)
The Weekly (80)
Vaccines (1030)
Venture capital (96)
Weight loss (402)
Women's health (87)
Worklife (20)
Date
Today (60)
Last 7 days (608)
Last 30 days (2062)
Last 365 days (30614)
2026 (2960)
2025 (31011)
2024 (36000)
2023 (40706)
2022 (51900)
2021 (56368)
2020 (54689)
2019 (47153)
2018 (35599)
2017 (33138)
2016 (32595)
2015 (38465)
2014 (33845)
2013 (28962)
2012 (29450)
2011 (30119)
2010 (28199)
Location
Africa (819)
Alabama (84)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (41263)
Australia (6916)
California (11328)
Canada (3273)
China (1133)
Colorado (477)
Connecticut (476)
Delaware (334)
Europe (90202)
Florida (1672)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (881)
India (63)
Indiana (519)
Iowa (23)
Japan (427)
Kansas (130)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1392)
Massachusetts (8171)
Michigan (321)
Minnesota (636)
Mississippi (5)
Missouri (127)
Montana (34)
Nebraska (29)
Nevada (122)
New Hampshire (79)
New Jersey (3029)
New Mexico (29)
New York (2991)
North Carolina (1484)
North Dakota (9)
Northern California (5522)
Ohio (330)
Oklahoma (22)
Oregon (41)
Pennsylvania (2280)
Puerto Rico (22)
Rhode Island (47)
South America (1201)
South Carolina (65)
South Dakota (1)
Southern California (4393)
Tennessee (172)
Texas (1745)
United States (40255)
Utah (341)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (936)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
742,650 Results for "edesa biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edesa Biotech Reports Fiscal Year 2025 Results
December 15, 2025
·
8 min read
Press Releases
Edesa Biotech Announces Upcoming November 2025 Conference Schedule
November 2, 2025
·
3 min read
Press Releases
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
October 29, 2025
·
9 min read
Press Releases
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
August 8, 2025
·
10 min read
Edesa Biotech to Participate in Upcoming Investor Conferences
Edesa Biotech, Inc. announced today that Edesa management plans to participate in the following upcoming investor conferences.
April 2, 2024
·
3 min read
Opinion
Trump Must Make Biotech Innovation a National Priority
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
January 14, 2026
·
7 min read
·
Cyriac Roeding
Press Releases
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
April 28, 2025
·
3 min read
Press Releases
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
May 15, 2025
·
10 min read
Press Releases
Edesa Biotech Announces Chief Financial Officer Transition
April 7, 2025
·
4 min read
Insights
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
After years of contraction, investors see biotech reentering a growth cycle driven by scientific progress, asset quality and renewed conviction in oncology, obesity and neuroscience innovation.
January 29, 2026
·
3 min read
·
Jennifer Smith-Parker
1 of 74,265
Next
